jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

July. 25, 2024

July. 25, 2024

jRCT1042240062

Comparative Study of Synaptic Density and Mitochondrial Function in Anorexia Nervosa and Healthy Individuals Using Positron Emission Tomography

In vivo PET Study of Synaptic Density and Mitochondrial Function in Anorexia Nervosa

Yamasue Hidenori

Hamamatsu University School of Medicine

1-20-1 Handayama, Chuo-ku, Hamamatsu city, Shizuoka

+81-53-435-2295

yamasue@hama-med.ac.jp

Yokokura Masamichi

Hamamatsu University School of Medicine

1-20-1 Handayama, Chuo-ku, Hamamatsu city, Shizuoka

+81-53-435-2295

ykkr@hama-med.ac.jp

Pending

July. 25, 2024

60

Observational

non-randomized controlled trial

open(masking not used)

no treatment control/standard of care control

parallel assignment

basic science

1) Female
2) Individuals aged between 18 and 50 years at the time of consent
3) Individuals who have provided consent through signing the informed consent form
4) (Applicable only to patients with anorexia nervosa) Individuals diagnosed with anorexia nervosa according to the DSM-5, the international diagnostic criteria

1) Individuals with a current or past history of organic brain diseases
2) Individuals with mitochondrial diseases
3) Individuals with coexisting substance-related disorders
4) Individuals who are pregnant or may be pregnant
5) Individuals unable to undergo PET due to claustrophobia or similar reasons
6) Individuals unable to undergo MRI due to the presence of metallic implants (such as brain clips or pacemakers) or tattoos
7) (Applicable only to healthy individuals) Individuals with a current or past history of mental disorders

18age old over
50age old under

Female

Anorexia nervosa

Anorexia nervosa

D000856

Thalamic SUVR values of [11C]UCB-J and [18F]BCPP-EF in patients with anorexia nervosa and healthy subjects

1) SUVR values of [11C]UCB-J and [18F]BCPP-EF in brain regions other than the thalamus in patients with anorexia nervosa and healthy subjects.
2) Psychological and clinical assessments: Evaluation of general mental disorders (SCID), symptom evaluation of AN (EDI-2), depression assessment (BDI-2), intellectual ability assessment (JART), stress and anxiety assessment (STAI), social and economic status assessment (SES), handedness assessment (Edinburgh Handedness Inventory).
3) MRI: MRS imaging to measure metabolite concentrations such as GABA and glutamate, resting-state functional MRI to measure functional connectivity, DTI imaging to measure neural fiber tracts.

Ethics Committee of Hamamatsu University School of Medicine
1-20-1, Handayama, Chuo-ku, Hamamatsu, Shizuoka, Shizuoka

+81-53-435-2680

rinri@hama-med.ac.jp
Approval

April. 04, 2024

No

none